TAKE Solutions Limited (TAKE.BO) Stock Analysis & Winston Score
TAKE Solutions Limited is an Indian company that provides technology and services to help pharmaceutical and life sciences companies manage complex regulatory and supply chain processes. Its core offerings include regulatory information management, clinical data management, and supply chain solutions, serving drug makers, biotech firms, and medical device companies that need to comply with strict government rules around the world. The company earns revenue primarily through long-term service contracts and software licensing fees paid by its life sciences clients, operating mainly across India, the United States, and parts of Europe and Asia. Its competitive position rests on deep domain expertise in pharmaceutical regulations, which creates switching costs once clients integrate TAKE's systems into their compliance workflows. However, the company's negative gross and operating margins signal that it is currently spending more than it earns, and returning to profitability — while managing competition from larger global IT services firms — remains the central challenge facing the business.
Winston Score: 22/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Mixed (3/10)
- Ownership: Good (10/15)
Key Facts
Price: 21.01 INR
Market Cap: 3.1B INR
Sector: Healthcare
Industry: Biotechnology
Exchange: Bombay Stock Exchange


